The Role of DOC-2/DAB2 in Modulating Androgen Receptor–Mediated Cell Growth via the Nongenomic c-Src–Mediated Pathway in Normal Prostatic Epithelium and Cancer
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Prostate cancer is initially responsive to androgen ablation, but prostate cancer tumors invariably progress to an androgen-independent state that is ultimately lethal. The onset of the androgen-independent prostate cancer is often associated with up-regulation of the androgen receptor that can cause antagonists to exhibit agonistic activity, which could lead to the failure of androgen ablation therapy. We describe a unique protein—DOC-2/DAB2 (differentially expressed in ovarian cancer-2/disabled 2)—that antagonizes androgen receptor–mediated cell growth in prostate cancer cells via interaction with c-Src protein. This interaction causes inactivation of Erk and Akt proteins critical for proliferation and survival of prostate cancer cells. However, DOC-2/DAB2 does not change the capacity of androgen receptor to regulate the transcription of androgen-responsive reporter genes, indicating that DOC-2/DAB2 selectively inhibits androgen receptor–mediated cell growth in androgen-independent prostate cancer by disrupting the androgen receptor/c-Src complex. In normal prostatic epithelia, DOC-2/DAB2 protein levels are more abundant than androgen receptor protein levels and reduced endogenous DOC-2/DAB2 protein levels in these cells by DOC-2/DAB2 RNA interference result in enhancing androgen receptor–mediated cell growth. We conclude that DOC-2/DAB2 can modulate androgen receptor–mediated cell growth in both normal and malignant prostatic epithelial cells and the outcome of this study could evolve into a new therapeutic strategy of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278 · cited 1×
“A recent study (3) indicates that overexpression of androgen receptor can cause antagonists to exhibit agonistic activity and also hypersensitizes androgen receptor activity in androgen-independent prostate cancer, which provides these cells”
BackgroundAndrogen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Cited by
Cinar, B., Mukhopadhyay, N. K., Meng, G., & Freeman, M. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703310200 · Cited by 92
Dey, N., De, P. K., Wang, M., Zhang, H., Dobrota, E. A., Robertson, K. A., & Durden, D. L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01352-06 · Cited by 62
“Finally, the recent evidence that CSK and SRC regulate nongenomic androgen receptor signals (74) suggests that this signaling axis may have an impact on hormone-induced signals that relate to cellular transformation in epithelial cells.”
BackgroundLoss of disabled-2 expression is an early event in esophageal squamous tumorigenesis
Anupam, K. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i37.6041 · Cited by 45
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer
Bagadi, S. A. R., Prasad, C. P., Srivastava, A., Prashad, R., Gupta, S. D., & Ralhan, R. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9422-6 · Cited by 40
Huang, C.-H., Cheng, J.-C., Chen, J.-C., & Tseng, C.-P. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.01.019 · Cited by 29
Self-citation
Metadata
- Authors
- Zhoul, J., Hernandez, G., Tu, S.-W., Huang, C.-L., Tseng, C.-P., & Hsieh, J.-T.
- Venue
- Cancer Research
- Published
- 2005-11-01
- Volume
- 65
- Issue
- 21
- Pages
- 9906-9913
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W1989214629
- Cited by
- 60
- References
- 2
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of DOC-2/DAB2 in Modulating Androgen Receptor–Mediated Cell Growth via the Nongenomic c-Src–Mediated Pathway in Normal Prostatic Epithelium and Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-05-1481
- The paper
- Zhoul, J., Hernandez, G., Tu, S.-W., Huang, C.-L., Tseng, C.-P., & Hsieh, J.-T. (2005). The Role of DOC-2/DAB2 in Modulating Androgen Receptor–Mediated Cell Growth via the Nongenomic c-Src–Mediated Pathway in Normal Prostatic Epithelium and Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-05-1481
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.